Skip to content
The Policy VaultThe Policy Vault

Lanreotide subcutaneous injection – Cipla — Medica

Carcinoid syndrome

Initial criteria

  • Medication is prescribed by or in consultation with an oncologist, endocrinologist, or gastroenterologist

Approval duration

1 year